Home / Drug shortages / Rocuronium Bromide Injection

Rocuronium Bromide Injection — FDA Drug Shortage

Current — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status Current. The shortage was first posted on 02/15/2023.

Shortage Details

Status
Current
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-4200-2
Dosage Form
Injection
Presentation
Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)
Initial Posting
02/15/2023
Revised Date

FDA data resources